skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Discovery of a cryptic peptide-binding site on PCSK9 and design of antagonists

Authors:
; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ORCiD logo
Publication Date:
Research Org.:
Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
Sponsoring Org.:
INDUSTRY
OSTI Identifier:
1463729
Resource Type:
Journal Article
Journal Name:
Nature Structural & Molecular Biology
Additional Journal Information:
Journal Volume: 24; Journal Issue: 10; Journal ID: ISSN 1545-9993
Publisher:
Nature Publishing Group
Country of Publication:
United States
Language:
ENGLISH

Citation Formats

Zhang, Yingnan, Ultsch, Mark, Skelton, Nicholas J., Burdick, Daniel J., Beresini, Maureen H., Li, Wei, Kong-Beltran, Monica, Peterson, Andrew, Quinn, John, Chiu, Cecilia, Wu, Yan, Shia, Steven, Moran, Paul, Di Lello, Paola, Eigenbrot, Charles, and Kirchhofer, Daniel. Discovery of a cryptic peptide-binding site on PCSK9 and design of antagonists. United States: N. p., 2017. Web. doi:10.1038/nsmb.3453.
Zhang, Yingnan, Ultsch, Mark, Skelton, Nicholas J., Burdick, Daniel J., Beresini, Maureen H., Li, Wei, Kong-Beltran, Monica, Peterson, Andrew, Quinn, John, Chiu, Cecilia, Wu, Yan, Shia, Steven, Moran, Paul, Di Lello, Paola, Eigenbrot, Charles, & Kirchhofer, Daniel. Discovery of a cryptic peptide-binding site on PCSK9 and design of antagonists. United States. doi:10.1038/nsmb.3453.
Zhang, Yingnan, Ultsch, Mark, Skelton, Nicholas J., Burdick, Daniel J., Beresini, Maureen H., Li, Wei, Kong-Beltran, Monica, Peterson, Andrew, Quinn, John, Chiu, Cecilia, Wu, Yan, Shia, Steven, Moran, Paul, Di Lello, Paola, Eigenbrot, Charles, and Kirchhofer, Daniel. Mon . "Discovery of a cryptic peptide-binding site on PCSK9 and design of antagonists". United States. doi:10.1038/nsmb.3453.
@article{osti_1463729,
title = {Discovery of a cryptic peptide-binding site on PCSK9 and design of antagonists},
author = {Zhang, Yingnan and Ultsch, Mark and Skelton, Nicholas J. and Burdick, Daniel J. and Beresini, Maureen H. and Li, Wei and Kong-Beltran, Monica and Peterson, Andrew and Quinn, John and Chiu, Cecilia and Wu, Yan and Shia, Steven and Moran, Paul and Di Lello, Paola and Eigenbrot, Charles and Kirchhofer, Daniel},
abstractNote = {},
doi = {10.1038/nsmb.3453},
journal = {Nature Structural & Molecular Biology},
issn = {1545-9993},
number = 10,
volume = 24,
place = {United States},
year = {2017},
month = {8}
}

Works referenced in this record:

On the size of the active site in proteases. I. Papain
journal, April 1967

  • Schechter, Israel; Berger, Arieh
  • Biochemical and Biophysical Research Communications, Vol. 27, Issue 2, p. 157-162
  • DOI: 10.1016/S0006-291X(67)80055-X

Peptidomimetics - Antagonists of the Fibrinogen Receptors: Molecular Design, Structures, Properties and Therapeutic Applications
journal, May 2004

  • Andronati, S. A.; Karaseva, T. L.; Krysko, A. A.
  • Current Medicinal Chemistry, Vol. 11, Issue 9
  • DOI: 10.2174/0929867043365314

Overview of the CCP 4 suite and current developments
journal, March 2011

  • Winn, Martyn D.; Ballard, Charles C.; Cowtan, Kevin D.
  • Acta Crystallographica Section D Biological Crystallography, Vol. 67, Issue 4
  • DOI: 10.1107/S0907444910045749

Permanent Alteration of PCSK9 With In Vivo CRISPR-Cas9 Genome Editing
journal, August 2014


Structural and biophysical studies of PCSK9 and its mutants linked to familial hypercholesterolemia
journal, April 2007

  • Cunningham, David; Danley, Dennis E.; Geoghegan, Kieran F.
  • Nature Structural & Molecular Biology, Vol. 14, Issue 5
  • DOI: 10.1038/nsmb1235

Applications of Combinatorial Technologies to Drug Discovery. 1. Background and Peptide Combinatorial Libraries
journal, April 1994

  • Gallop, Mark A.; Barrett, Ronald W.; Dower, William J.
  • Journal of Medicinal Chemistry, Vol. 37, Issue 9
  • DOI: 10.1021/jm00035a001

Inclisiran in Patients at High Cardiovascular Risk with Elevated LDL Cholesterol
journal, April 2017

  • Ray, Kausik K.; Landmesser, Ulf; Leiter, Lawrence A.
  • New England Journal of Medicine, Vol. 376, Issue 15
  • DOI: 10.1056/NEJMoa1615758

A Small-Molecule Anti-secretagogue of PCSK9 Targets the 80S Ribosome to Inhibit PCSK9 Protein Translation
journal, November 2016


PCSK9 inhibitors and cardiovascular disease: heralding a new therapeutic era
journal, January 2015


Antisense-mediated reduction of proprotein convertase subtilisin/kexin type 9 (PCSK9): a first-in-human randomized, placebo-controlled trial: Antisense-mediated reduction of PCSK9, a first-in-human study
journal, October 2015

  • van Poelgeest, Eveline P.; Hodges, Michael R.; Moerland, Matthijs
  • British Journal of Clinical Pharmacology, Vol. 80, Issue 6
  • DOI: 10.1111/bcp.12738

PCSK9 inhibitors: monoclonal antibodies for the treatment of hypercholesterolemia
journal, January 2016


The self-inhibited structure of full-length PCSK9 at 1.9 A reveals structural homology with resistin within the C-terminal domain
journal, September 2007

  • Hampton, E. N.; Knuth, M. W.; Li, J.
  • Proceedings of the National Academy of Sciences, Vol. 104, Issue 37
  • DOI: 10.1073/pnas.0703402104

Sequence Variations in PCSK9, Low LDL, and Protection against Coronary Heart Disease
journal, March 2006

  • Cohen, Jonathan C.; Boerwinkle, Eric; Mosley, Thomas H.
  • New England Journal of Medicine, Vol. 354, Issue 12
  • DOI: 10.1056/NEJMoa054013

A Highly Durable RNAi Therapeutic Inhibitor of PCSK9
journal, January 2017

  • Fitzgerald, Kevin; White, Suellen; Borodovsky, Anna
  • New England Journal of Medicine, Vol. 376, Issue 1
  • DOI: 10.1056/NEJMoa1609243

From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors
journal, February 2017

  • Ashkenazi, Avi; Fairbrother, Wayne J.; Leverson, Joel D.
  • Nature Reviews Drug Discovery, Vol. 16, Issue 4
  • DOI: 10.1038/nrd.2016.253

New developments in proprotein convertase subtilisin–kexin 9ʼs biology and clinical implications
journal, January 2016


Structure of a Serine Protease Proteinase K from Tritirachium album limber at 0.98 Å Resolution
journal, March 2001

  • Betzel, Christian; Gourinath, S.; Kumar, Pravindra
  • Biochemistry, Vol. 40, Issue 10
  • DOI: 10.1021/bi002538n

High-affinity Human Antibodies from Phage-displayed Synthetic Fab Libraries with a Single Framework Scaffold
journal, July 2004

  • Lee, Chingwei V.; Liang, Wei-Ching; Dennis, Mark S.
  • Journal of Molecular Biology, Vol. 340, Issue 5
  • DOI: 10.1016/j.jmb.2004.05.051

Calcium-Independent Inhibition of PCSK9 by Affinity-Improved Variants of the LDL Receptor EGF(A) Domain
journal, October 2012

  • Zhang, Yingnan; Zhou, Lijuan; Kong-Beltran, Monica
  • Journal of Molecular Biology, Vol. 422, Issue 5
  • DOI: 10.1016/j.jmb.2012.06.018

Molecular basis for LDL receptor recognition by PCSK9
journal, February 2008

  • Kwon, H. J.; Lagace, T. A.; McNutt, M. C.
  • Proceedings of the National Academy of Sciences, Vol. 105, Issue 6
  • DOI: 10.1073/pnas.0712064105

XDS
journal, January 2010

  • Kabsch, Wolfgang
  • Acta Crystallographica Section D Biological Crystallography, Vol. 66, Issue 2
  • DOI: 10.1107/S0907444909047337

ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
journal, January 2013

  • Souers, Andrew J.; Leverson, Joel D.; Boghaert, Erwin R.
  • Nature Medicine, Vol. 19, Issue 2
  • DOI: 10.1038/nm.3048

Mutations in PCSK9 cause autosomal dominant hypercholesterolemia
journal, May 2003

  • Abifadel, Marianne; Varret, Mathilde; Rabès, Jean-Pierre
  • Nature Genetics, Vol. 34, Issue 2
  • DOI: 10.1038/ng1161

The biology and therapeutic targeting of the proprotein convertases
journal, April 2012

  • Seidah, Nabil G.; Prat, Annik
  • Nature Reviews Drug Discovery, Vol. 11, Issue 5
  • DOI: 10.1038/nrd3699

Potential of Proprotein Convertase Subtilisin/Kexin Type 9 Based Therapeutics
journal, February 2013


Bivalent antibody phage display mimics natural immunoglobulin
journal, January 2004

  • Lee, Chingwei V.; Sidhu, Sachdev S.; Fuh, Germaine
  • Journal of Immunological Methods, Vol. 284, Issue 1-2
  • DOI: 10.1016/j.jim.2003.11.001

Catalytic Activity Is Not Required for Secreted PCSK9 to Reduce Low Density Lipoprotein Receptors in HepG2 Cells
journal, May 2007

  • McNutt, Markey C.; Lagace, Thomas A.; Horton, Jay D.
  • Journal of Biological Chemistry, Vol. 282, Issue 29
  • DOI: 10.1074/jbc.C700095200

Design and Synthesis of Truncated EGF-A Peptides that Restore LDL-R Recycling in the Presence of PCSK9 In Vitro
journal, February 2014


The crystal structures of two cuticle-degrading proteases from nematophagous fungi and their contribution to infection against nematodes
journal, May 2010

  • Liang, Lianming; Meng, Zhaohui; Ye, Fengping
  • The FASEB Journal, Vol. 24, Issue 5
  • DOI: 10.1096/fj.09-136408

Design, Synthesis, and Biological Activity of a Potent Smac Mimetic That Sensitizes Cancer Cells to Apoptosis by Antagonizing IAPs
journal, September 2006

  • Zobel, Kerry; Wang, Lan; Varfolomeev, Eugene
  • ACS Chemical Biology, Vol. 1, Issue 8
  • DOI: 10.1021/cb600276q

Disrupting the PCSK9/LDLR protein–protein interaction by an imidazole-based minimalist peptidomimetic
journal, January 2016

  • Stucchi, Mattia; Grazioso, Giovanni; Lammi, Carmen
  • Organic & Biomolecular Chemistry, Vol. 14, Issue 41
  • DOI: 10.1039/C6OB01642A

Selective stalling of human translation through small-molecule engagement of the ribosome nascent chain
journal, March 2017


Structure and Function Analysis of Peptide Antagonists of Melanoma Inhibitor of Apoptosis (ML-IAP)
journal, July 2003

  • Franklin, Matthew C.; Kadkhodayan, Saloumeh; Ackerly, Heidi
  • Biochemistry, Vol. 42, Issue 27
  • DOI: 10.1021/bi034227t

NMR View: A computer program for the visualization and analysis of NMR data
journal, September 1994

  • Johnson, Bruce A.; Blevins, Richard A.
  • Journal of Biomolecular NMR, Vol. 4, Issue 5
  • DOI: 10.1007/BF00404272

Features and development of Coot
journal, March 2010

  • Emsley, P.; Lohkamp, B.; Scott, W. G.
  • Acta Crystallographica Section D Biological Crystallography, Vol. 66, Issue 4
  • DOI: 10.1107/S0907444910007493

Identifying specificity profiles for peptide recognition modules from phage-displayed peptide libraries
journal, May 2007

  • Tonikian, Raffi; Zhang, Yingnan; Boone, Charles
  • Nature Protocols, Vol. 2, Issue 6
  • DOI: 10.1038/nprot.2007.151

REFMAC 5 for the refinement of macromolecular crystal structures
journal, March 2011

  • Murshudov, Garib N.; Skubák, Pavol; Lebedev, Andrey A.
  • Acta Crystallographica Section D Biological Crystallography, Vol. 67, Issue 4
  • DOI: 10.1107/S0907444911001314

Secreted PCSK9 promotes LDL receptor degradation independently of proteolytic activity
journal, August 2007

  • Li, Jun; Tumanut, Christine; Gavigan, Julie-Ann
  • Biochemical Journal, Vol. 406, Issue 2
  • DOI: 10.1042/BJ20070664

PHENIX: a comprehensive Python-based system for macromolecular structure solution
journal, January 2010

  • Adams, Paul D.; Afonine, Pavel V.; Bunkóczi, Gábor
  • Acta Crystallographica Section D Biological Crystallography, Vol. 66, Issue 2, p. 213-221
  • DOI: 10.1107/S0907444909052925

PCSK9: a convertase that coordinates LDL catabolism
journal, November 2008

  • Horton, Jay D.; Cohen, Jonathan C.; Hobbs, Helen H.
  • Journal of Lipid Research, Vol. 50, Issue Supplement
  • DOI: 10.1194/jlr.R800091-JLR200

Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
journal, May 2017

  • Sabatine, Marc S.; Giugliano, Robert P.; Keech, Anthony C.
  • New England Journal of Medicine, Vol. 376, Issue 18
  • DOI: 10.1056/NEJMoa1615664

Furin-cleaved Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Is Active and Modulates Low Density Lipoprotein Receptor and Serum Cholesterol Levels
journal, November 2012

  • Lipari, Michael T.; Li, Wei; Moran, Paul
  • Journal of Biological Chemistry, Vol. 287, Issue 52
  • DOI: 10.1074/jbc.M112.380618

NMRPipe: A multidimensional spectral processing system based on UNIX pipes
journal, November 1995

  • Delaglio, Frank; Grzesiek, Stephan; Vuister, GeertenW.
  • Journal of Biomolecular NMR, Vol. 6, Issue 3
  • DOI: 10.1007/BF00197809

Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients
journal, April 2017

  • Ridker, Paul M.; Revkin, James; Amarenco, Pierre
  • New England Journal of Medicine, Vol. 376, Issue 16
  • DOI: 10.1056/NEJMoa1701488

Data processing and analysis with the autoPROC toolbox
journal, March 2011

  • Vonrhein, Clemens; Flensburg, Claus; Keller, Peter
  • Acta Crystallographica Section D Biological Crystallography, Vol. 67, Issue 4
  • DOI: 10.1107/S0907444911007773

Structural and Biochemical Characterization of the Wild Type PCSK9-EGF(AB) Complex and Natural Familial Hypercholesterolemia Mutants
journal, November 2008

  • Bottomley, Matthew J.; Cirillo, Agostino; Orsatti, Laura
  • Journal of Biological Chemistry, Vol. 284, Issue 2
  • DOI: 10.1074/jbc.M808363200

The crystal structure of the proprotein processing proteinase furin explains its stringent specificity
journal, June 2003

  • Henrich, Stefan; Cameron, Angus; Bourenkov, Gleb P.
  • Nature Structural & Molecular Biology, Vol. 10, Issue 7
  • DOI: 10.1038/nsb941

Function Blocking Antibodies to Neuropilin-1 Generated from a Designed Human Synthetic Antibody Phage Library
journal, February 2007

  • Liang, Wei-Ching; Dennis, Mark S.; Stawicki, Scott
  • Journal of Molecular Biology, Vol. 366, Issue 3
  • DOI: 10.1016/j.jmb.2006.11.021

Identification of a Small Peptide That Inhibits PCSK9 Protein Binding to the Low Density Lipoprotein Receptor
journal, November 2013

  • Zhang, Yingnan; Eigenbrot, Charles; Zhou, Lijuan
  • Journal of Biological Chemistry, Vol. 289, Issue 2
  • DOI: 10.1074/jbc.M113.514067

Peptide-Based Anti-PCSK9 Vaccines - An Approach for Long-Term LDLc Management
journal, December 2014


Phaser crystallographic software
journal, July 2007

  • McCoy, Airlie J.; Grosse-Kunstleve, Ralf W.; Adams, Paul D.
  • Journal of Applied Crystallography, Vol. 40, Issue 4
  • DOI: 10.1107/S0021889807021206